Brian Benari - Challenger CEO, Managing Director, Executive Director
CFIGY Stock | USD 43.70 0.00 0.00% |
CEO
Mr. Brian Roland Benari is no longer Chief Executive Officer, Managing Director and Executive Director of Challenger Ltd., effective January 2019. Mr. Benari commenced in the role of Managing Director and Chief Executive Officer on 17 February 2012, having previously been Challenger Group CFOGroup COO for over three years. Joining Challenger in March 2003 Mr Benari established and was founding Chief Executive of Challenger Mortgage Management division. In this role he oversaw the development of the business to include residential and commercial mortgage lending arms, as well as acquiring three of the four largest mortgage distribution broker platform businesses in Australia. Over a period of five years, CMM grew its mortgage lending assets to in excess of 23 billion and was Australia largest independent mortgage lender. Through its platforms, the business managed over 110 billion of mortgages under administration. The business was sold in 2009 to the National Australia Bank. Having originally qualified as a chartered accountant, Mr Benari joined Challenger with many years of finance industry experience, both offshore and onshore. He has held senior executive roles with institutions including JP Morgan, Bankers Trust, Macquarie Bank and Zurich Capital Markets. Mr. Benari was a director of Homeloans Limited from 3 May 2007 until 17 February 2012. since 2012.
Tenure | 12 years |
Phone | 61 2 9994 7000 |
Web | https://challenger.com.au |
Challenger Management Efficiency
Challenger's management efficiency ratios could be used to measure how well Challenger manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 5 records | CEO Age | ||
Todd Nelson | CECO Environmental Corp | 58 | |
Mark Beck | Jeld Wen Holding | 50 | |
David Auld | DR Horton | 68 | |
Humberto Carpio | Cementos Pacasmayo SAA | 60 | |
Montgomery Moran | Chipotle Mexican Grill | 48 |
Management Performance
Return On Equity | 0.0649 | |||
Return On Asset | -0.0074 |
Challenger ADR Leadership Team
Elected by the shareholders, the Challenger's board of directors comprises two types of representatives: Challenger inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Challenger. The board's role is to monitor Challenger's management team and ensure that shareholders' interests are well served. Challenger's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Challenger's outside directors are responsible for providing unbiased perspectives on the board's policies.
Graham Cubbin, Non-Executive Independent Director | ||
Jeremy Cooper, Chairman Income | ||
Jane Keeley, Head Communications | ||
Angela Murphy, Executive General Manager - Human Resources | ||
Richard Howes, Chief Executive of Challenger Life Company Limited | ||
Nicolas Hamilton, CEO MD | ||
Leon Zwier, Non-Executive Independent Director | ||
Duncan West, Non-Executive Independent Director | ||
JoAnne Stephenson, Independent Non-Executive Director | ||
Robert Woods, Chief Executive - Funds Management | ||
BBuild AMP, Head Property | ||
Christopher Plater, Deputy Officer | ||
Brian Benari, CEO, Managing Director, Executive Director | ||
Richard Willis, Chief Risk Officer | ||
Andrew Brown, Company Secretary | ||
Louise Roche, Chief Officer | ||
Peter Polson, Independent Non-Executive Chairman of the Board | ||
Brenda Shanahan, Non-Executive Independent Director | ||
Paul Rogan, Chief Executive - Distribution, Product and Marketing | ||
Jonathan Grunzweig, Non-Executive Independent Director | ||
Mark Chen, Gen Relations | ||
John Green, Non-Executive Independent Director | ||
Andrew Tobin, CFO | ||
Steven Gregg, Independent Non-Executive Director | ||
Rachel AM, Chief Officer | ||
Melanie Willis, Non-Executive Independent Director | ||
Michael Vardanega, General Counsel, Group Company Secretary | ||
Ian Saines, Chief Executive - Funds Management | ||
Chris Plater, Chief Executive - Life | ||
Alexandra Bell, Chief Officer | ||
Anton Kapel, Actuary Solutions |
Challenger Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Challenger a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0649 | |||
Return On Asset | -0.0074 | |||
Profit Margin | 0.50 % | |||
Operating Margin | (0.70) % | |||
Current Valuation | (10.74 B) | |||
Shares Outstanding | 68.39 M | |||
Price To Earning | 19.21 X | |||
Price To Book | 1.03 X | |||
Price To Sales | 6.75 X | |||
Revenue | 1.36 B |
Pair Trading with Challenger
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Challenger position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Challenger will appreciate offsetting losses from the drop in the long position's value.Moving against Challenger Pink Sheet
0.69 | URYL | United Royale Holdings | PairCorr |
0.53 | AZRH | Azure Holding Group | PairCorr |
The ability to find closely correlated positions to Challenger could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Challenger when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Challenger - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Challenger Ltd ADR to buy it.
The correlation of Challenger is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Challenger moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Challenger ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Challenger can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Challenger Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Challenger ADR information on this page should be used as a complementary analysis to other Challenger's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Challenger Pink Sheet analysis
When running Challenger's price analysis, check to measure Challenger's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Challenger is operating at the current time. Most of Challenger's value examination focuses on studying past and present price action to predict the probability of Challenger's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Challenger's price. Additionally, you may evaluate how the addition of Challenger to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |